Introducing the Most Advanced Alternative to Thorough QT Studies
Please join Daniel Goodman, MD, Vice President and Medical Director at BioTelemetry Research for a complimentary webinar on EvriBeat – Dynamic Electrocardiography. This webinar will guide you through BioTelemetry Research’s exclusive offering, EvriBeat, an advanced method for assessing cardiac safety in early human trials. EvriBeat provides a powerful and efficient alternative to Thorough QT studies and it is ideal for SAD/MAD protocols, providing definitive QTc data earlier and more affordably than other methods.
Key topics will include:
- Continuous recording and analysis features
- Complete, continuous 24-hour Holter data, beat-to-beat QT and RR data
- Concentration-Regression analysis features
- Additional procedures available on-demand and much more!
Join us to learn how you can potentially collect your QTc data earlier while also reducing costs with EvriBeat – Dynamic Electrocardiography.
Not sure if you want to exhibit at or attend the EvriBeat - Dynamic Electrocardiography? See the panels below to get the information you need to make an informed decision.
|Conference/Event Dates:||06/15/2016 - 06/15/2016|
|Primary Industry:||Clinical Pharmacology|
|Other Industries:||Clinical Pharmacology, Pharmaceutical, Professional Healthcare|
|Audience:||This webinar will benefit professionals within biopharmaceutical research and medical device organizations, specifically those in the following roles:
Chief Medical Officer
VP Clinical Operations
VP Clinical Development
Director Clinical Operations
Director Clinical Development
Director, Clinical Pharmacology Unit, Phase I
Medical Director, Phase I
|Booth Size||Booth Cost||Available Amenities|
|Marketing Vehicles Allowed:||n/a|
|Other Booth Sizes Available: n/a|
How do I show up here?
Add a note here, it is only visible by you.